Priavoid is a clinical stage drug development company based in Düsseldorf, Germany. Its therapeutic focus is on protein misfolding disorders in the area of neurodegeneration. Key component of Priavoid's technology is an anti-oligomeric or anti-prionic mode of action, that efficiently and effectively disassembles neurotoxic aggregates by using all-D-peptides.
Company Details
- Employees
- 17
- Founded
- -
- Address
- Merowingerplatz 1a, Düsseldorf,north Rhine-Westphalia 40225,germany
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- priavoid.com
- Keywords
- All-D-peptides, Neurodegenerative diseases, Alzheimer´s disease, Parkinson´s disease, Tauopathies, central nervous system, A-beta peptide, toxic oligomers, mirror image phage display, Neuropathic Pain, Amyotrophic Lateral Sclerosis.
- HQ
- Düsseldorf, North Rhine-Westphalia
Priavoid Gmbh Questions
Priavoid Gmbh's website is priavoid.com
Priavoid Gmbh's LinkedIn profile is https://de.linkedin.com/company/priavoid-gmbh
Priavoid Gmbh has
17 employees.
View email and phone details for 17
employees at Priavoid Gmbh.
Priavoid Gmbh's industry is
Pharmaceutical Manufacturing
Priavoid Gmbh's top competitors are
Mindcraft Ag,
Leniobio,
Dynavax Gmbh,
Detechgene,
Attyloid Gmbh,
Abalos Therapeutics Gmbh,
Numaferm,
Navigo Proteins Gmbh,
Evoenzyme,
Prinnovation Gmbh.
Priavoid Gmbh's categories are Pharmaceutical Manufacturing
Priavoid Gmbh's founding year is 2017
